600285 羚锐制药
2023/09 - 九个月
人民币(K¥)
与去年末期
比较
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
2019/12
人民幣(K¥)

非流动资产
长期股权投资71,425-0.32%71,652117,10398,58165,351
投资性房地产0--0000
固定资产652,009-6.43%696,816697,992727,256757,006
在建工程884-54.05%1,92424,7752,7759,032
无形资产205,4110.87%203,646236,946235,040242,053
商誉0--000500
其他非流动资产1,255,99145.71%861,952585,035477,564487,475
2,185,71919.05%1,835,9901,661,8501,541,2161,561,417

流动资产
货币资金1,217,8273.27%1,179,296801,242732,317741,211
应收账款294,82850.44%195,973172,906145,720172,511
存货454,613-6.54%486,411428,389331,412286,681
其他流动资产479,090-25.92%646,712728,700707,092553,957
2,446,359-2.47%2,508,3932,131,2371,916,5411,754,361

流动负债
短期借款101,7878.50%93,811126,33820,000135,000
应付票据0--0000
应付帐款74,95510.19%68,02178,01178,80967,660
其他流动负债1,661,5837.19%1,550,1161,233,299967,449811,131
1,838,3267.38%1,711,9481,437,6481,066,2571,013,791
流动资产净值608,033-23.66%796,444693,589850,284740,570
资产总额减流动负债2,793,7526.13%2,632,4342,355,4392,391,4992,301,987

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债75,0141.41%73,96868,86469,34581,541
75,0141.41%73,96868,86469,34581,541

总权益
    实收股本567,144-0.06%567,459567,759567,809567,809
    储备项目2,143,9748.09%1,983,4601,711,2311,744,9151,642,079
股东权益2,711,1186.28%2,550,9192,278,9902,312,7242,209,888
非控股权益7,6200.97%7,5477,5869,43010,558